Attending TechBio UK
400+ attendees
50+ expert speakers
*Early-stage companies: Companies that have raised less than £5 million and with sales of less than £2 million a year. Note: prices include attendance to the conference and post-conference drinks. Check the 'programme' tab for the details. |
Kings Place
90 York Way
London
N1 9AG
The TechBioUK audience will comprise of biotech and TechBio C-Suite, pharma, investors, legal, BD and financial experts.
2023 attendees included:
CBO, Co-Founder |
CDO |
CEO |
CEO & Cofounder |
CEO & Co-founder |
CEO and Founder |
CEO Engagement Lead |
CEO, Nye Health, NHS GP and Doll Fellow |
CFO |
Chair |
Chair & CEO |
Chair of the Board |
Chairperson |
Chief Business Officer |
Chief Business Strategy Officer |
Chief Consulting Officer |
Chief Evangelist |
Chief Executive Officer |
Chief Medical and Product Officer |
Chief Operations Officer |
Chief Real-World Data Officer |
Chief Technology Officer |
Client Growth Manager, Imperial Business Partners |
Clinical Policy Manager |
CMO, Life Sciences |
co-CEO |
Co-CEO and Commercial Lead |
Co-CEO and CTO |
Co-Founder |
Co-Founder & CEO |
Co-Founder & CTO |
Co-founder & GP |
Commercial Asset Manager |
Commercial Director |
Computational Lead |
Consultant |
COO |
COO & Co-founder |
Corporate Development |
Corporate Development Director |
CTO |
Data Engineer |
Deputy Director, Data For R&D |
Deputy Head of Life Sciences |
Deputy Head, Investment Promotion |
Digital & Data Science Innovation Lead |
Digital Marketing Executive |
Director |
Director - Biotech |
Director – Business Development |
Director - Health & Life Sciences |
Director – Healthcare, Pharma, Medtech |
Director Illumina For Startups, Global Ecosystem Development |
Director External Innovation |
Director of Clinical Analytics and Data Science |
Director of Communications |
Director of External Affairs |
Director of HealthTech |
Director of Life Science Partnerships |
Director of Life Science Programmes |
Director of Operations |
Director of Partnerships |
Director of Research, Development and Innovation |
Director Operations and Business Engagement |
Director R&D Strategic Operations UK |
Director Research Operations |
Director, BD, Licensing and Strategy |
Director, R&D Clinical informatics Portfolio |
Early Innovation Partnering - EMEA Lead, Data Science and Retina |
Ecosystem Manager, UK & Ireland |
Entrepreneur in Residence |
Entrepreneurship and Business Development Director |
European Managing Director |
European Sales Director |
EVP |
Executive Director |
Executive Director & UK Partnering Lead |
Founder |
Founder & CEO |
Founder and CEO |
Founder and Chief Science Officer |
Founder and Creative Director |
Founder and Managing Partner |
Founder/CEO |
Founder/CTO |
Global Head of BD for Omics |
Global Pharmaceuticals Correspondent |
Head of Access to Finance & Skills, Office for Life Sciences |
Head of AI |
Head of Architecture |
Head of Business |
Head of Cross Government Data Strategy |
Head of Data Science |
Head of Data Strategy and Partnerships |
Head of Discovery, Synthetic Biology |
Head of Engineering Biology and Tech Strategy |
Head of Growth, Healthcare & Life Sciences Startups |
Head of Innovation |
Head of Innovation & Technology |
Head of Legal, Trust & Ethics |
Head of LifeArc Ventures |
Head of Manufacturing Innovation |
Head of NHS Research SDE Network: Data for R&D |
Head of Operations, People and Tech |
Head of Partnerships |
Head of R&D |
Head of Strategy and Operations |
Head of Strategy: Data for R&D | NHS Transformation Directorate |
Head of Translation |
Head of UK Life Sciences |
Head of Urban Dynamics |
Head of Venture Foundry |
HFSP Research Fellow |
Industry Partnerships and Commercialisation Officer |
Innovation Lead |
Innovation Manager |
Investment Director Life Sciences |
Investment Manager |
Investment Professional |
Investor |
IPC Officer |
IT Business Partner |
Lead Programme Manager |
Life Science Specialist |
Life Sciences Business Development Manager |
Life Sciences Specialist |
Machine Learning Engineer |
Manager, Solution Consulting |
Managing Associate |
Managing Director |
Managing Partner |
MD |
Non-Executive Director |
NURTuRE operational manager |
Operations Executive |
Partner |
PDRA |
Philanthropic Fund Manager |
President |
Principal |
Principal Bioinformatician |
Principal Investor |
Principal Scientist |
Principal Scientist, Preclinical Research |
Programme Manager |
Project Coordinator |
Project Manager |
Relationship Manager |
Science Collaboration Manager |
Science Director |
Senior Director of Emerging Innovations |
Senior Director, Assay Development and High-Throughput Screening |
Senior Health Studies Development Manager |
Senior Investment Manager |
Senior Investment Principal |
Senior Manager, Life Sciences |
Senior Process Development Scientist II - CMC Systems |
Senior Scientist |
Senior Strategic Marketing Manager |
Senior Vice President R&D Strategy |
Special Counsel |
Strategy Director |
SVP Data Science and Informatics |
SVP External Affairs and Investor Relations |
SVP Growth |
SVP, Informatics |
Technical Architect |
Territory Sales Manager |
Trainee Patent Attorney |
Translational Research Manager |
TTM |
UK Account Manager |
Venture BuilderVenture |
Venture capital investor |
Venture Partner |
Vice President, Consulting & Analytics |
Vice President, Marketing |
Vice President, Technology |
Visiting Researcher |
VP & General Manager |
VP & General Manager UK & Ireland |
VP Corporate Development |
VP International Expansion |
3PM |
AI VIVO |
Alchemab Therapeutics |
Allen & Overy LLP |
AltemisLab Ltd |
Amazon Web Services EMEA SARL, UK Branch |
AMPLY Discovery |
AMRC (Association of Medical Research Charities) |
ARCH Venture Partners |
Arcturis Data Limited |
Arnold & Porter Kaye Scholer LLP |
Astex Pharmaceuticals |
AstraZeneca UK Ltd |
Axia Medicine |
BC Platforms |
BioInnovation Institute |
BioPartner UK |
BIOS Health |
BioScience Managers Ltd |
Bit Bio Ltd |
Bitrobius Genetics Ltd |
Bloomberg |
Bold Health |
BPC |
Brainomix |
Bridge Partners |
Bristol BioDesign Institute |
British Patient Capital |
Bruntwood Sci Tech |
C4X Discovery Ltd |
Cambridge Consultants Ltd |
Cambridge Innovation Capital Limited |
Cancer Research Horizons |
CardiaTec Biosciences Ltd |
Carpmaels & Ransford LLP |
Cathay Capital |
CC Bio |
Celeris Therapeutics |
Cell and Gene Therapy Catapult |
Centre For Process Innovation Ltd |
Charles River Laboratories |
CHARM Therapeutics |
Citeline |
Citigroup |
Closed Loop Medicine |
CMPM Ltd |
Colorifix |
ConcR Ltd |
Cooley (UK) LLP |
Covington |
CPI |
Cresset Group |
Cystic Fibrosis Trust |
Cytiva |
D Young & Co LLP |
Daset Labs |
DeepMirror |
Department for Business and Trade |
Department for Science, Innovation and Technology |
Discovery Park Ltd |
Eagle Genomics Ltd |
Earlham Institute |
Earlybird VC |
Eczacibaşi Pharmaceutical and Industrial Investment Co. |
Eliptica |
Enara Bio Limited |
Epidarex Capital |
Erebagen |
Etcembly Ltd |
Evaluate |
Evariste |
Evolutor |
Evolvere Future of Health |
Exogene |
ExpressionEdits Ltd |
F Hoffmann-La Roche Ltd |
Fieldfisher LLP |
Financial Times |
Firefinch Software Ltd |
First Create the Media |
Francis Crick Institute |
Gallagher |
Genevation Ltd |
Giant Ventures |
Gill Jennings and Every |
Graeme Hills Consultancy Services Limited |
Ground Truth Labs Ltd |
H Tree Capital |
Hamill Life Sciences Ltd |
HDR UK |
Healx |
HLX Group |
Human Centric Drug Discovery |
IBioIC |
iGEM Venture Foundry |
Ignota Labs |
Illumina Cambridge Ltd |
Immunocore Limited |
Imperial College Health Partners |
Imperial College London |
Indicro Ltd |
Innovate UK |
Intellegens |
Invest HK |
Invest Northern Ireland |
Itecho Health |
Ixion |
Jiva.ai |
JLL |
Johnson & Johnson Innovation |
Kadans Science Partner |
Kidney Research UK |
Kilburn & Strode LLP |
Kings College London |
Kuano |
LabGenius |
Lateral |
Latham & Watkins (London) LLP |
Life Science People |
LifeArc |
Lifebit Biotech Ltd |
Lindus Health |
London BioScience Innovation Centre (LBIC) |
London School of Hygiene and Tropical Medicine |
M:M Bio Ltd |
MedCity |
MedTech SuperConnector |
Mercia Asset Management |
MFX |
Milner Therapeutics Institute, University of Cambridge |
Mission Asset Management |
Moderna UK |
Molten Ventures |
Monument Therapeutics |
Mosaic Therapeutics Limited |
MultiOmic Health |
Mursla Bio |
Nashville Biosciences |
National Institute of Health Research |
Native Labs |
Neobe Therapeutics Ltd |
NG Bio |
NHS England |
NHS England and Improvement |
Norwich Research Park |
Nucleome Therapeutics |
O2H Ltd |
Ochre Bio Ltd |
Octopus Ventures Ltd |
Office for Life Sciences (UK) |
One Nucleus Limited |
Ori Biotech |
Osborne Clarke |
Other |
Owkin |
Oxford University |
Oxford University NHS Trust |
PacBio |
Pangea Botanica |
Panmure Gordon |
Parkwalk Advisors Limited |
Pear Bio |
PetMedix |
PharmEnable Therapeutics Limited |
PhoreMost Ltd |
Pinsent Masons LLP |
Pioneer Group |
Potter Clarkson LLP |
Precisia Clinical Risk Analytics |
PrecisionLife Ltd |
Prokarium Ltd |
Recode Health Ventures |
Relation Therapeutics |
Reliance Health |
Sanna Science |
Serna Bio |
Sifted |
Sixfold Bioscience Ltd |
SMi Drug Discovery |
SökerData |
Solena Materials |
Stephenson Harwood LLP |
Stevenage Bioscience Catalyst |
Stratagem IPM Ltd |
Sun Bear Biofuture |
Syngene International |
Taylor Wessing LLP |
T-Cypher Bio Ltd |
The Francis Crick Institute |
The National, London Bureau |
The Wellcome Trust |
Tony Blair Institute for Global Change |
Translational Research Hub, University of Bristol |
Trinova Consulting |
Triple Chasm |
TTP Group |
Turing Biosystems Ltd |
Tweidpharma |
UCL |
Ulster University |
University Hospitals Birmingham NHS Trust |
University of Bath |
University of Cambridge |
University of Oxford |
VectorBuilder Ltd |
We are Pioneer Group |
Weatherden Limited |
Wellcome |
Wellcome Sanger Institute |
Wilson Sonsini Goodrich & Rosati (UK) LLP |
Zuhlke |
Zyme Communications Ltd |
PAYMENT OF FEES
By completing the event registration form, the attendee is committing to attend and therefore pay for the applicable amount (complying with the cancellation policy below).
All payments should be made prior to the event
You are encouraged to pay by means of credit and debit card or you can choose the invoice option. Invoices should be paid within 30 days of the invoice date.
If you wish to pay by BACS, please send remittance advice to [email protected]
Bank name:
Lloyds, 1 High Street, Carfax, Oxford, OX1 4AA
Sort Code: 30-96-35
A/c No: 00069829
Swift Code: LOYDGB2L
Payment can also be made online via the link that is on the invoice.
CANCELLATIONS AND REFUNDS
All cancellations must be made in writing by email to Sam Care at [email protected].
- Bookings cancelled on or after 30 September will remain fully payable.
- Cancellations made before then will be subject to a 20% cancellation fee.
We encourage you to send a colleague in your place where possible.
Should we cancel, postpone the event or change its format to a virtual or hybrid one, you will be entitled to cancel your registration and to receive a full refund. The deadline to request this cancellation and refund will be communicated if and when this change happens.
VENUE AND EVENT ACCESSIBILITY
We are regularly monitoring changes in government regulations around events. We recommend all attendees take a lateral flow test no more than 24 hours prior to the event. We advise any attendees who are not feeling well or who are displaying Covid-19 symptoms to please not attend.
Alternative or additional precautions like the wearing of masks inside the venue might also be considered and requested.
DATA COLLECTION AND USE
Your full name, company name, email address, dietary requirements and telephone number will be collected upon registration and used to contact you with regard to this event. Your data will be processed and stored as per our privacy statement: https://www.bioindustry.org/privacy-statement.html
Your full name, company name and dietary requirements might be shared with Kings Place if required by them in order to allow you access to their premises and in order to accommodate any dietary requirements you might have provided.
PHOTOGRAPHY AND VIDEO
We take photographs at all of our events and occasionally record videos. Photos and videos are often used for marketing purposes (e.g.: on Twitter, on direct marketing emails, etc). If you do not wish for photos or a video of you to be made public, please let us know by emailing [email protected]
DELEGATE LIST
At many of our events, we distribute delegates lists to attendees. These lists consist of the full name and company name of all registered attendees, but do not include contact details such as email addresses. We don’t allow third parties to use these lists for promotional purposes without your express consent. If you don’t want to be on the delegate list for an event, please let us know by emailing [email protected]
The data that the BIA will collect from you will be treated in accordance with the above and with our privacy statement. This is necessary in order for you to be able to join the event and is, therefore, a precondition of service
For further information, please contact:
Sam Care
Head of Events, BIA
Sam Care
Head of Events, BIA
What does your role at BIA involve?
Sam leads the events team at BIA, working on developing and expanding BIA's extensive events programme as well as evolving BIA's existing sector-leading events. Sam overseas the end-to-end event logistics, marketing strategy, planning and execution of the events programme and is also responsible for building exciting event supporter opportunities for BIA members. She also helped establish the Women in Biotech mentoring programme and is responsible for the smooth running of the scheme.
Previous experience & achievements
Sam has extensive experience in events and business development roles, having previously worked at the Chartered Governance Institute developing and delivering their event & training programme. She also worked on a joint project with Sport England helping to establish the Sports Governance Academy and has previously worked in recruitment. Sam has a degree in Business Studies from the University of Liverpool.
Join the BIA TechBio LinkedIn Group and start connecting with others from the TechBio community.
Have you seen our TechBio report?
TechBio 2023: UK driving the AI revolution highlights the UK TechBio sector as thriving, with a growing number of companies pioneering groundbreaking products and services, seamlessly integrating biotechnology and technology.